| Literature DB >> 26074789 |
Lars I E Oddsson1, Marsha J Finkelstein2, Sarah Meissner2.
Abstract
Evidence-based guidelines recommend early functional rehabilitation of stroke patients when risk of patient harm can be managed. Current tools do not allow balance training under load conditions sufficiently low for acute stroke patients. This single-arm pilot study tested feasibility and safety for acute stroke survivors to use "Balance-Bed", a technology for balance exercises in supine initially developed to emulate microgravity effects on balance. Nine acute stroke patients (50-79 years) participated in 3-10 sessions over 16-46 days as part of their rehabilitation in a hospital inpatient setting. Standard inpatient measures of outcome were monitored where lack of progress from admission to discharge might indicate possible harm. Total FIM scores at admission (median 40, range 22-53) changed to (74, 50-96), Motor FIM scores from (23, 13-32) to (50, 32-68) and Berg Balance scores from (3, 0-6) to (19, 7-43) at discharge. Changes reached Minimal Clinical Important Difference for a sufficient proportion (>0.6) of the patients to indicate no harm to the patients. In addition, therapists reported the technology was safe, provided a positive experience for the patient and fit within the rehabilitation program. They reported the device should be easier to set up and exit. We conclude acute stroke patients tolerated Balance-Bed exercises such as standing on one or two legs, squats, stepping in place as well as balance perturbations provided by the therapist. We believe this is the first time it has been demonstrated that acute stroke patients can safely perform whole body balance training including balance perturbations as part of their rehabilitation program. Future studies should include a control group and compare outcomes from best practices to interventions using the Balance-Bed. In addition, the technology is relevant for countermeasure development for spaceflight and as a test-bed of balance function under microgravity-like conditions.Entities:
Keywords: acute stroke; balance function; body weight support; countermeasure; microgravity; rehabilitation
Year: 2015 PMID: 26074789 PMCID: PMC4445307 DOI: 10.3389/fnsys.2015.00083
Source DB: PubMed Journal: Front Syst Neurosci ISSN: 1662-5137
Figure 1Subject demonstrating the Balance-Bed device used in the current study. (A) The ceiling mounted whole body mirror and gridline for body alignment and perceived vertical showed from subject’s perspective. (B) Subject in two-leg squat position. (C) Subject in two-leg “upright” standing position.
Therapist evaluation of the Balance-Bed.
| Statement | Agree strongly (n) | Agree (n) | Neutral (n) | Disagree (n) |
|---|---|---|---|---|
| Beneficial to patient | 1 | 2 | 0 | 0 |
| Allows safe challenge of balance | 2 | 1 | 0 | 0 |
| Fits within stroke rehab program | 1 | 2 | 0 | 0 |
| Seems to improve patients’ upright function | 0 | 3 | 0 | 0 |
| “Unusually” strong progress noticed | 0 | 0 | 3 | 0 |
| Patient appeared comfortable | 0 | 2 | 1 | 0 |
| Patient had positive experience | 1 | 2 | 0 | 0 |
| Patient was safe | 3 | 0 | 0 | 0 |
| Tilting is useful | 1 | 2 | 0 | 0 |
| Loading range is sufficient | 1 | 1 | 1 | 0 |
| Setup was simple | 0 | 1 | 1 | 1 |
| Exit was simple, (missing = 1) | 0 | 1 | 0 | 1 |
Subject characteristics.
| Subject | Age | Gender | LOS (days) | Time (days) | Side | Primary diagnosis | # Sessions |
|---|---|---|---|---|---|---|---|
| 1 | 71 | M | 46 | 7 | L | R MCA ischemic stroke | 10 |
| 2 | 73 | M | 16 | 8 | L + R | L cerebellar hemorrhagic stroke with craniotomy | 4 |
| 3 | 58 | M | 26 | 5 | R | L parenchymal and subarachnoid intraventricular hemorrhage | 6 |
| 4 | 59 | M | 28 | 8 | L + R | L cerebellar ischemic stroke with craniotomy | 5 |
| 5 | 68 | F | 38 | 36 | L | Hypoxic ischemic encephalopathy | 9 |
| 6 | 75 | M | 37 | 17 | L | R frontal, parenchymal and basal ganglia hemorrhagic stroke | 7 |
| 7 | 79 | M | 28 | 9 | L | R MCA ischemic stroke | 5 |
| 8 | 79 | F | 29 | 8 | L | B cerebral hemisphere and cerebellum infarcts | 3 |
| 9 | 50 | M | 43 | 6 | L | R posterior basal ganglia ischemic stroke with anaplastic astrocytoma | 7 |
| Median (Range) | 71 (50–79) | 29 (16–46) | 8 (5–36) | 6 (3–10) |
Activity Log used for Balance-Bed training sessions.
| Exercise/Activity | Patient # |
|---|---|
| Standing 2-leg normal base EO | 112222333344445566666777 |
| Standing 2-leg narrow base EO | 3 |
| Standing 2-leg normal base EC | 3444 |
| Standing 2-leg narrow base EC | |
| Standing R-leg EO | 449 |
| Standing L-leg EO | 11111111449 |
| Standing R-leg EC | 4 |
| Standing L-leg EC | 14 |
| Standing weight shift EO | 222248889999999 |
| Standing weight shift EC | 99 |
| Squat 2-leg EO | 11222233333444445555556666666777778889999999 |
| Squat 2-leg EC | 3333444456 |
| Squat R-leg EO | 233344444566667 |
| Squat R-leg EC | 34 |
| Squat L-leg EO | 1111111111233344444555555555666666677777999999 |
| Squat L-leg EC | 34 |
| Step-in-place EO | 2224668 |
| Step-in-place EC | |
| Perturbations | 11112222344444556666677788899 |
Acronyms: EO, Eyes open; EC, Eyes closed; R, Right; L, Left. A separate log was used for each patient and each session. Column with Patient # indicates which exercise patients experienced and for how many session, e.g., 449 for the exercise “Standing R-leg EO” means that patient #4 experienced this exercise at two sessions and patient #9 at one session. The following information (not shown in the Table) was also collected for each training session: Duration (min), # Reps, # Sets, Foam (Y/N), Tilt (deg), Load (#cords).
Standard inpatient outcome measures for participating patients showing values at admission (Pre), discharge (Post) as well as change for total Functional Independence Measures (FIM), FIM Motor and Berg Balance Scale (BBS) scores.
| Subject | FIM total pre | FIM total post | FIM total change | FIM motor pre | FIM motor post | FIM motor change | BBS pre | BBS post | BBS change | # Sessions |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 22 | 72 | 50* | 13 | 44 | 31* | 3 | 11 | 8* | 10 |
| 2 | 37 | 50 | 13 | 24 | 32 | 8 | 6 | 7 | 1 | 4 |
| 3 | 47 | 95 | 48* | 32 | 68 | 36* | 4 | 43 | 39* | 6 |
| 4 | 43 | 96 | 53* | 28 | 65 | 37* | 4 | 22 | 18* | 5 |
| 5 | 39 | 60 | 21* | 17 | 37 | 20* | 0 | N/A | N/A | 9 |
| 6 | 40 | 66 | 26* | 18 | 43 | 25* | 2 | 15 | 13* | 7 |
| 7 | 39 | 82 | 43* | 17 | 55 | 38* | 1 | 33 | 32* | 5 |
| 8 | 53 | 87 | 34* | 25 | 59 | 34* | 4 | 23 | 19* | 3 |
| 9 | 43 | 74 | 31* | 23 | 50 | 27* | 1 | 16 | 15* | 7 |
| Median | 40 | 74 | 34 | 23 | 50 | 31 | 3 | 19 | 16.5 | 6 |
| Range | 22–53 | 50–96 | 13–53 | 13–32 | 32–68 | 8–38 | 0–6 | 7–43 | 1–39 | 3–10 |
Measures were used to demonstrate no harm to the patients if changes exceeded MCID for each of the outcomes (22, 17, and 5 for FIM Total, FIM Motor, and BBS, respectively). Patients who reached MCID for each of the outcomes are indicated with an asterisk.